Vascular Cell Adhesion Molecule-1 (VCAM-1) plays a major role in the chronic inflammatory processes involved in vulnerable atherosclerotic plaque development. We previously showed that the technetium-labeled HMC-I derived peptide B2702p bound specifically to VCAM-1 and allowed the ex vivo imaging of atherosclerotic lesions in WHHL rabbits. However, B2702p target-to-background ratio was suboptimal for the in vivo imaging of VCAM-1 expression in atherosclerotic lesions. In order to improve the target-tobackground ratio, twenty derivatives of B2702p (B2702p1 to B2702p20) were
1 expression in atherosclerotic lesions. In order to improve the target-tobackground ratio, twenty derivatives of B2702p (B2702p1 to B2702p20) were synthesized using the ALA-scan methodology. We hypothesized that technetium-radiolabeled B2702p derivatives might allow the molecular imaging of VCAM-1 expression in an experimental model of atherosclerosis.
Methods -A mouse model of focal atherosclerotic plaque development
induced by left carotid artery ligation in ApoE -/-mice was used (n = 82). 
Conclusion99m
Tc-B2702p1 is a potentially useful radiotracer for the in vivo molecular imaging of VCAM-1 expression in atherosclerotic plaques.
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INTRODUCTION
Cardiovascular diseases (CVD) represent the first cause of mortality worldwide (1), mostly because there is an unmet need for an efficient screening prevention strategy as illustrated by the fact that sudden cardiac death and acute myocardial infarction are the first symptoms of so far asymptomatic atherosclerosis in >50% of CVD patients (2) . A non invasive test allowing the detection of coronary vulnerable atherosclerotic lesions in asymptomatic patients prior to the occurence of a cardiovascular event would therefore greatly participate to the overall effort aimed at decreasing the burden of cardiovascular diseases (1) (2) (3) (4) . Nuclear molecular imaging would be perfectly suited for this purpose due to the functional nature of the informations provided by this non invasive imaging methodology (5) . A number of molecular targets have been evaluated for the development of corresponding specific radiolabeled imaging agents (6) . Among other relevant molecules, Vascular Cell Adhesion Molecule -1 (VCAM-1) is a wellrecognized marker of atherosclerotic plaque vulnerability (3, 4, (7) (8) (9) since its overexpression was observed over the complete course of vulnerable plaque development (10, 11) . In addition, the overexpression of VCAM-1 is strictly restricted to areas of plaque development (7) , and a number of cell types participating to the evolution of a given atherosclerotic lesion towards a vulnerable plaque overexpress VCAM-1, namely luminal endothelial cells (12) , macrophages (13) , smooth muscle cells (14) as well as intraplaque neovessels (10 
MATERIALS AND METHODS

Peptide Synthesis and Radiolabeling
The peptidic sequences of B2702p1-20 are presented in were anesthetized using an intraperitoneal injection of xylazine (1/3; 10 mg/kg) and ketamine (2/3; 100 mg/kg). A skin incision was performed at the level of the thyroid gland and the left common carotid artery was ligated near the bifurcation using 5-0 silk (Ethicon). The incision was then sutured and the animals were allowed to return to individual cages.
In Vivo Imaging and Biodistribution Studies.
Three weeks following left carotid artery ligation, the animals were reanesthetized as described above and 34.7 ± 0.8 MBq of tracer were injected through a tail vein. The animals were then placed on the parallel-hole collimator of a small animal dedicated gamma-camera (Gamma-Imager,
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Biospace Lab, Paris, France) and planar imaging was performed for 180 min in the list mode using a 125-150 keV energy window with anesthesia being maintained using isoflurane 1%. High-resolution, pinhole SPECT imaging of Tc-B2702p1 were also determined following i.v. injection as described above and euthanasia followed by blood withdrawal and left & right carotid excision at 15 (n=3) and 60 min (n=3) post-injection. The tissue samples and organs were quickly rinsed and weighted and their activities were assessed using a gamma-well counter (Cobra II, Packard Instruments) and a 100-168 keV energy window. Tracer activity was expressed as % of the injected dose per gram of wet weight (%ID/g). Urinary and blood sampling was also performed in order to assess the stability of the injected tracers using HPLC as decribed above.
Histology & Immunohistology.
Standard trichrome HES staining (Haematoxylin, Erythrosine, Safran) for nuclei, cytoplasm and fibrosis staining, and immunohistological staining of VCAM-1 and Mac-2 were performed using previously described procedures (21) .
Statistical Analysis.
Values are presented as mean ± SD. Statistical computations were performed using SYSTAT software (SPSS, Inc.). Between-groups comparisons were performed using unpaired t-test and Kruskal-Wallis test whereas within-group analysis was performed using one-way analysis of variance and Wilcoxon sign-rank test. P values≤0.05 were considered statistically significant.
RESULTS
Histology & Immunohistology
As shown in Figure 1 tracer injection as a consequence of the three-week time interval between surgery and image acquisition allowing complete healing of the incision site.
Biodistribution Studies
As indicated in Table 1 , the radiolabeling of all peptidic sequences was successfully performed with a RCP>88% with the exception of B2702p5 (RCP  50%) which was therefore not further considered for evaluation. All radiotracers displayed good urinary stability with the exception of B2702p7
and B2702p16. The 180-min biodistribution of all radiotracers is presented in Table 2 . The kidneys represented the preferential route of excretion for all tracers except for Tc-B2702p1 mismatch, Tc-B2702p7, and Tc-B2702p9 for which the hepatobiliary route was equally involved. Significant thyroid uptake likely indicative of radiolabeling instability following in vivo injection was observed for Tc-B2702p, Tc-B2702p11, Tc-B2702p12, Tc-B2702p13, TcB2702p14, Tc-B2702p15, and Tc-B2702p18. Tc-B2702p1 and Tc-B2702p18 left carotid activities were significantly higher than that observed in the right carotid artery. Shown in Figure 2 are the left-to-right carotid activity ratios (A) and left carotid-to-blood activity ratios (B) for all radiotracers. Tc-B2702p1 left-to-right carotid and left carotid-to-blood activity ratios at 180 min (2.6 ± 0.6 and 1.4 ± 0.4, respectively) were significantly higher than those of Tc- 
In Vitro Experiments
Results from fluorescence polarisation experiments are presented in Figure 6 . Derivated peptides were therefore initially generated following an ALA-scan methodology consisting in the systematic replacement of the original residues with an Ala in each position of the peptide. Additional modifications were also performed by inverting two residues prior to reiterating the ALA-scan methodology on the pre-modified peptide ( Table 1 ). The ALA-scan strategy has been previously used to investigate the structure-activity relationship of peptidic receptor antagonists (17) . ALA-scan modifications have been described to either decrease, have no effect, or possibly increase the potency and metabolic stability of the peptide being modified (17) (18) (19) .
Twenty peptides were therefore generated from the original B2702p sequence and labeled with 99m Tc using the Isolink ® method for biological evaluation on The affinity of the B2702p1 peptidic sequence for VCAM-1 was determined with fluorescence polarization using a similar methodology to that previously used to evaluate the Kd value corresponding to the interaction between B2702p and VCAM-1 (15) . The observed Kd value for the interaction between B2702p1 and VCAM-1 was ~15 µmol/L, a value ~50-fold higher than that observed for B2702, consistent with the observation that a decrease in ligand affinity is frequently observed when using the ALA-scan methodology (17) . Several peptidic VCAM-1 ligands were recently described.
In vitro phage display allowed the selection of the multimodal nanoparticle VNP (23), whereas in vivo phage display led to the discovery of VINP-28, a linear sequence which allowed the in vivo imaging of atherosclerotic lesions using MRI and optical imaging (24) . More recently, a tetrameric peptide of nanomolar affinity for VCAM-1 and consisting of 4 VINP-28 sequences allowed the nuclear imaging of apoE-/-mouse atherosclerotic lesion following radiolabelling with 18 F (25) . In addition, the recently described R832 short peptidic sequence was obtained using the in vitro phage display methodology as well. The peptide displayed a micromolar affinity for VCAM-1 and allowed the in vivo detection of VCAM-1 expression following conjugation to Gd-DOTA and MR imaging (26) . Taken altogether, the results from the above inserm-00831631, version 1 -7 Jun 2013 mentioned studies suggest that a wide range of affinities might be suitable for the non invasive imaging of molecular targets.
The affinity of the peptidic sequence B2702p1 described in the present study for VCAM-1 is similar to that of R832. Importantly, the discrete amino acid modifications that led to the B2702p1 peptide from the original B2702p sequence led to a decreased circulating activity for Tc-B2702p1 when compared to Tc-B2702p. Indeed, Tc-B2702p1 blood activity was >6-fold lower than that observed for Tc-B2702p, leading to a target-to-background ratio suitable for in vivo imaging. On the other hand, the elevated circulating blood activity of Tc-B2702p together with a suboptimal stability of the tracer following in vivo injection as illustrated by the significant thyroid activity prevented the successful obtention of in vivo images of VCAM-1 expression. 
CONCLUSION
